Denali Therapeutics Depreciation & Amortization 2011-2026 | DNLI

Annual Depreciation & Amortization Denali Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
7.8 M	16.7 M	10.4 M	8.59 M	8.53 M	7.99 M	7.42 M	3.08 M	1.47 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.7 M	1.47 M	8 M

Quarterly Depreciation & Amortization Denali Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	2.32 M	-	-	-	2.16 M	-	-	-	10 M	-	6.29 M	4.15 M	2.08 M	-	6.5 M	4.31 M	2.11 M	-	6.41 M	4.25 M	2.11 M	-	5.94 M	4.05 M	2.4 M	-	5.04 M	2.71 M	854 K	-	2.28 M	1.5 M	731 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10 M	731 K	3.73 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Cerus Corporation CERS	1.43 M	$ 2.72	33.99 %	$ 518 M	USA
ACADIA Pharmaceuticals ACAD	920 K	$ 21.95	-2.23 %	$ 3.64 B	USA
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Cardiff Oncology CRDF	364 K	$ 1.71	-1.16 %	$ 114 M	USA
Caladrius Biosciences CLBS	174 K	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Editas Medicine EDIT	5.28 M	$ 2.9	-3.33 %	$ 257 M	USA
Dynavax Technologies Corporation DVAX	4.63 M	-	-	$ 2.02 B	USA
Edesa Biotech EDSA	186 K	$ 17.59	-3.75 %	$ 56.2 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.93	-8.15 %	$ 4.82 M	Israel
Eiger BioPharmaceuticals EIGR	275 K	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	77 K	-	-5.68 %	$ 8.28 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA